Literature DB >> 10330182

Structural and functional heterogeneity of nuclear bodies.

D B Bloch1, J D Chiche, D Orth, S M de la Monte, A Rosenzweig, K D Bloch.   

Abstract

The nuclear body is a cellular structure that appears to be involved in the pathogenesis of acute promyelocytic leukemia and viral infection. In addition, the nuclear body is a target of autoantibodies in patients with the autoimmune disease primary biliary cirrhosis. Although the precise function of the nuclear body in normal cellular biology is unknown, this structure may have a role in the regulation of gene transcription. In a previous investigation, we identified a leukocyte-specific, gamma interferon (IFN-gamma)-inducible autoantigen designated Sp140. The objectives of the present study were to investigate the cellular location of Sp140 with respect to the nuclear-body components PML and Sp100 and to examine the potential role of Sp140 in the regulation of gene transcription. We used adenovirus-mediated gene transfer to express Sp140 in human cells and observed that the protein colocalized with PML and Sp100 in resting cells and associated with structures containing PML during mitosis. In cells infected with the adenovirus expressing Sp140 and incubated with IFN-gamma, the number of PML-Sp100 nuclear bodies per cell increased but immunoreactive Sp140 was not evenly distributed among the nuclear bodies. Sp140 associated with a subset of IFN-gamma-induced PML-Sp100 nuclear bodies. To examine the potential effect of Sp140 on gene transcription, a plasmid encoding Sp140 fused to the DNA-binding domain of GAL4 was cotransfected into COS cells with a chloramphenicol acetyltransferase (CAT) reporter gene containing five GAL4-binding sites and a simian virus 40 enhancer region. The GAL4-Sp140 fusion protein increased the expression of the reporter gene. In contrast, Sp100 fused to the GAL4 DNA-binding domain inhibited CAT activity in transfected mammalian cells. The results of this study demonstrate that Sp140 associates with a subset of PML-Sp100 nuclear bodies in IFN-gamma-treated cells and that Sp140 may activate gene transcription. Taken together, these observations suggest that the nuclear bodies within a cell may be heterogeneous with respect to both composition and function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330182      PMCID: PMC104401          DOI: 10.1128/MCB.19.6.4423

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

2.  Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.

Authors:  V J LaMorte; J A Dyck; R L Ochs; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Role of PML in cell growth and the retinoic acid pathway.

Authors:  Z G Wang; L Delva; M Gaboli; R Rivi; M Giorgio; C Cordon-Cardo; F Grosveld; P P Pandolfi
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

4.  A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins.

Authors:  S S Kim; Y M Chen; E O'Leary; R Witzgall; M Vidal; J V Bonventre
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  Identification and characterization of a leukocyte-specific component of the nuclear body.

Authors:  D B Bloch; S M de la Monte; P Guigaouri; A Filippov; K D Bloch
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

6.  Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.

Authors:  K Weis; S Rambaud; C Lavau; J Jansen; T Carvalho; M Carmo-Fonseca; A Lamond; A Dejean
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

7.  Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).

Authors:  T Grötzinger; T Sternsdorf; K Jensen; H Will
Journal:  Eur J Biochem       Date:  1996-06-01

8.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

9.  Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias.

Authors:  L Longo; P P Pandolfi; A Biondi; A Rambaldi; A Mencarelli; F Lo Coco; D Diverio; L Pegoraro; G Avanzi; A Tabilio
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.

Authors:  T Sternsdorf; K Jensen; H Will
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  20 in total

1.  Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

Authors:  Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

3.  DADLE induces a reversible hibernation-like state in HeLa cells.

Authors:  Lorella Vecchio; Cristiana Soldani; Maria Grazia Bottone; Manuela Malatesta; Terence E Martin; Lawrence I Rothblum; Carlo Pellicciari; Marco Biggiogera
Journal:  Histochem Cell Biol       Date:  2005-10-18       Impact factor: 4.304

4.  Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Authors:  Florian A Marquardsen; Fabian Baldin; Florian Wunderer; Waleed Al-Herz; Raymond Mikhael; Gérard Lefranc; Zeina Baz; Fariba Rezaee; Rabi Hanna; Shlomit Kfir-Erenfeld; Polina Stepensky; Benedikt Meyer; Annaise Jauch; Marc B Bigler; Anne-Valérie Burgener; Rebecca Higgins; Alexander A Navarini; Joeseph A Church; Janet Chou; Raif Geha; Luigi D Notarangelo; Christoph Hess; Christoph T Berger; Donald B Bloch; Mike Recher
Journal:  J Clin Immunol       Date:  2017-08-21       Impact factor: 8.317

5.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

6.  Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.

Authors:  H Li; C Leo; J Zhu; X Wu; J O'Neil; E J Park; J D Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140.

Authors:  Stuti Mehta; D Alexander Cronkite; Megha Basavappa; Tahnee L Saunders; Fatemeh Adiliaghdam; Hajera Amatullah; Sara A Morrison; Jose D Pagan; Robert M Anthony; Pierre Tonnerre; Georg M Lauer; James C Lee; Sreehaas Digumarthi; Lorena Pantano; Shannan J Ho Sui; Fei Ji; Ruslan Sadreyev; Chan Zhou; Alan C Mullen; Vinod Kumar; Yang Li; Cisca Wijmenga; Ramnik J Xavier; Terry K Means; Kate L Jeffrey
Journal:  Sci Immunol       Date:  2017-03-03

8.  Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.

Authors:  R T Zong; C Das; P W Tucker
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

9.  Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.

Authors:  D B Bloch; A Nakajima; T Gulick; J D Chiche; D Orth; S M de La Monte; K D Bloch
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

10.  Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.

Authors:  Navid Madani; Robert Millette; Emily J Platt; Mariana Marin; Susan L Kozak; Donald B Bloch; David Kabat
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.